Our Mission – the best, the fastest, the cheapest diagnostic tool against cancer.

At our company, we leverage our latest advancements in physical and chemical research to enhance MRI signals, advancing the field of medical imaging towards metabolic imagiung. Our patented, revolutionary contrast agent, based on a the human key metabolite pyruvate, enables us to visualize the energy metabolism on a cellular level and potentially detect pathological changes at their earliest stages.

Our innovative method is not only faster and more cost-effective than competing techniques in clinical research, but it also delivers exceptional signal amplification. We have already achieved signal enhancements of up to 30,000 times, with the potential to reach up to 70,000 times compared to conventional MRI, making it one of the most powerful tools available for early diagnosis and monitoring of metabolic diseases.

Our unique innovative synthesis enables us to produce the contrast agent in unprecedented yields. while our process has achieved yields of up to 70 %, the next best competitive method achieves yields of only 3 %.

place

Reached signal amplification

24000 fold

people

Future signal amplification

70000 fold

public

Patented syntesis with highest yield

70 %

WHO expects rapid rise in cancer cases

According to a forecast, the number of cancer cases worldwide will increase rapidly by 2050 - by up to 77 percent according to the WHO.

What are the causes of this increase? And which cancers are increasingly affecting younger people?

Our New Contrast Agent

We place great emphasis on maximum transparency from the very beginning. Since our contrast agent is injected into the body of the patients, it is only natural for us to fully disclose its structure and properties. This way, everyone can understand how our contrast agent works and that it is completely safe.

Related research

Hyperpolarization and metabolic imaging are currently among the hottest topics in research, aiming to revolutionize biomedical imaging by enabling unprecedented insights into real-time metabolism. Publications in this fiels saw a rapid growth and constant breakthroughs in recent years. We are at the forefront of the field with our publications, driving innovation.